BLU enhances the effects of anti-angiogenic activity in combination with gemcitabine-based chemotherapeutic agents

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 7, 2013, Pages 1236-1245

  Yoo, Heon Jong ^a   Kim, Boh Ram ^a   Byun, Hyun Jung ^a   Park, Sang Yoon ^a   Rho, Seung Bae ^a  

^a National Cancer Center   (South Korea)

Author keywords

Angiogenesis; Cell cycle arrest; Gemcitabine traditional chemotherapeutic agent; Tumor suppressor BLU gene; Tumorigenesis; VEGF receptor 2

Indexed keywords

BLU PROTEIN; GEMCITABINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; VASCULOTROPIN; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; HIF1A PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; PROTEIN BAX; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TARGET OF RAPAMYCIN KINASE; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN; ZMYND10 PROTEIN, HUMAN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OVARIAN NEOPLASMS; PHOSPHORYLATION; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

MAMMALIA;

3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DEOXYCYTIDINE; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RHO GTP-BINDING PROTEINS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84877026500     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.04.001     Document Type: Article

References (50)

1. M. Abe, M. Ohira, A. Kaneda, Y. Yagi, S. Yamamoto, and Y. Kitano CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas Cancer Research 65 2005 828 834 (Pubitemid 40216441)
2. B. Antonsson, and J.C. Martinou The Bcl-2 protein family Experimental Cell Research 256 2000 50 57 (Pubitemid 30211166)
3. J.L. Arbiser, T. Kau, M. Konar, K. Narra, R. Ramchandran, and S.A. Summers Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis Blood 109 2007 560 565 (Pubitemid 46105954)
4. A.M. Bergman, V.W.T. Ruiz van Haperen, Veerman, C.M. Kuiper, and G.J. Peters Synergistic interaction between Cisplatin and Gemcitabine in vitro Clinical Cancer Research 2 1996 521 530 (Pubitemid 26099172)
5. S. Bhoola, and W.J. Hoskins Diagnosis and management of epithelial ovarian cancer Obstetrics and Gynecology 107 2006 1399 1410 (Pubitemid 44336908)
6. A. Borgne, I. Versteege, M. Mahé, A. Studeny, S. Léonce, and I. Naime Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment Oncogene 25 2006 7361 7372 (Pubitemid 44853427)
7. C.T. Chiang, P.Y. Yeh, M. Gao, C.W. Chen, L.C. Yeh, and W.C. Feng Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma Cancer Letters 298 2010 195 203
8. S.M. Dong, H.J. Byun, B.R. Kim, S.H. Lee, B. Trink, and S.B. Rho Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction Cellular Signalling 24 2012 1208 1214
9. B. Fadeel, and S. Orrenius Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease Journal of Internal Medicine 258 2005 479 517 (Pubitemid 41705391)
10. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nature Reviews Cancer 2 2002 795 803 (Pubitemid 37328914)
11. L.A. Gomez, A. de Las Pozas, T. Reiner, K. Burnstein, and C. Perez-Stable Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy Molecular Cancer Therapeutics 6 2007 1534 1543 (Pubitemid 46954020)
12. D.A. Guertin, and D.M. Sabatini An expanding role for mTOR in cancer Trends in Molecular Medicine 11 2005 353 361 (Pubitemid 41080576)
13. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
14. L. Hesson, I. Bièche, D. Krex, E. Criniere, K. Hoang-Xuan, and E.R. Maher Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas Oncogene 23 2004 2408 2419 (Pubitemid 38496796)
15. L.B. Hesson, W.N. Cooper, and F. Latif Evaluation of the 3p21.3 tumour-suppressor gene cluster Oncogene 26 2007 7283 7301 (Pubitemid 350115980)
16. M. Ito, G. Ito, M. Kondo, M. Uchiyama, T. Fukui, and S. Mori Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer Cancer Letters 225 2005 131 139 (Pubitemid 40732776)
17. B.H. Jiang, J.Z. Zheng, M. Aoki, and P.K. Vogt Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells Proceedings of the National Academy of Sciences of the United States of America 97 2000 1749 1753 (Pubitemid 30118514)
18. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: a link between cancer genetics and chemotherapy Cell 108 2002 153 164 (Pubitemid 34161136)
19. A. Khwaja Akt is more than just a Bad kinase Nature 401 1999 33 34
20. M.A. Krasilnikov Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation Biochemistry 65 2000 59 67
21. H.C. Lai, Y.W. Lin, C.C. Chang, H.C. Wang, T.W. Chu, and M.H. Yu Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias Gynecologic Oncology 104 2007 629 635
22. O.H. Lee, Y.M. Kim, Y.M. Lee, E.J. Moon, D.J. Lee, and J.H. Kim Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells Biochemical and Biophysical Research Communications 264 1999 743 750
23. D. Lorusso, A. Di Stefano, F. Fanfani, and G. Scambia Role of gemcitabine in ovarian cancer treatment Annals of Oncology 17 2006 v188 v194
24. S.W. Lowe, and A.W. Lin Apoptosis in cancer Carcinogenesis 21 2000 485 495 (Pubitemid 30137934)
25. C.J. Marsit, D.H. Kim, M. Liu, P.W. Hinds, J.K. Wiencke, and H.H. Nelson Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence International Journal of Cancer 114 2005 219 223 (Pubitemid 40194289)
26. M.B. McMahon, M.D. Bear, S.K. Kulp, M.L. Pennell, and C.A. London Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro American Journal of Veterinary Research 71 2010 799 808
27. Q. Meng, C. Xia, J. Fang, Y. Rojanasakul, and B.H. Jiang Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway Cellular Signalling 18 2006 2262 2271 (Pubitemid 44636166)
28. M. Oren Decision making by p53: life, death and cancer Cell Death and Differentiation 10 2003 431 442 (Pubitemid 36626355)
29. G.J. Peters, C.J. Van Moorsel, B. Lakerveld, K. Smid, P. Noordhuis, and E.C. Comijn Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines International Journal of Oncology 28 2006 237 244
30. K.H. Plate, G. Breier, H.A. Weich, and W. Risau Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 359 1992 845 848
31. W. Plunkett, P. Huang, C.E. Searcy, and V. Gandhi Gemcitabine: preclinical pharmacology and mechanisms of action Seminars in Oncology 23 1996 3 15 (Pubitemid 26362189)
32. L.A. Porter, I.H. Cukier, and J.M. Lee Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis Blood 101 2003 1928 1933 (Pubitemid 36237595)
33. G.H. Qiu, L.K. Tan, K.S. Loh, C.Y. Lim, G. Srivastava, and S.T. Tsai The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma Oncogene 23 2004 4793 4806 (Pubitemid 38859468)
34. J.C. Reed Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies Seminars in Hematology 34 1997 9 19 (Pubitemid 28032415)
35. S.B. Rho, K. Choi, K. Park, and J.H. Lee Inhibition of angiogenesis by the BTB domain of promyelocytic leukemia zinc finger protein Cancer Letters 294 2010 49 56
36. S.B. Rho, M.J. Kim, J.S. Lee, W. Seol, H. Motegi, and S. Kim Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex Proceedings of the National Academy of Sciences of the United States of America 96 1999 4488 4493 (Pubitemid 29190363)
37. S.B. Rho, K.H. Lee, J.W. Kim, K. Shiba, Y.J. Jo, and S. Kim Interaction between human tRNA synthetases involves repeated sequence elements Proceedings of the National Academy of Sciences of the United States of America 93 1996 10128 10133 (Pubitemid 26314586)
38. S.B. Rho, Y.J. Song, M.C. Lim, S.H. Lee, B.R. Kim, and S.Y. Park Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2 Cellular Signalling 24 2012 131 139
39. E. Riquelme, M. Tang, S. Baez, A. Diaz, M. Pruyas, and I.I. Wistuba Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma Cancer Letters 250 2007 100 106 (Pubitemid 46483848)
40. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674 (Pubitemid 27193480)
41. Y. Sato, and D.B. Rifkin Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis Journal of Cell Biology 107 1988 1199 1205
42. J. Savill, and V. Fadok Corpse clearance defines the meaning of cell death Nature 407 2000 784 788
43. I. Shiojima, and K. Walsh Role of Akt signaling in vascular homeostasis and angiogenesis Circulation Research 90 2002 1243 1250 (Pubitemid 34787405)
44. C.H. Tang, X.Q. Liu, S.F. Yang, B. Zhu, and H.J. Gao Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo Zhonghua Zhong Liu Za Zhi 30 2008 808 812
45. L. Toschi, G. Finocchiaro, S. Bartolini, V. Gioia, and F. Cappuzzo Role of gemcitabine in cancer therapy Future Oncology 1 2005 7 17
46. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
47. K.H. Vousden, and D.P. Lane p53 in health and disease Nature Reviews Molecular Cell Biology 8 2007 275 283 (Pubitemid 46474662)
48. S.D. Westfall, and M.K. Skinner Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment Molecular Cancer Therapeutics 4 2005 1764 1771 (Pubitemid 41685311)
49. C. Xia, Q. Meng, Z. Cao, X. Shi, and B.H. Jiang Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression Journal of Cellular Physiology 209 2006 56 66 (Pubitemid 44318667)
50. W.D. Yu, Y. Ma, G. Flynn, J.R. Muindi, R.X. Kong, and D.L. Trump Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system Cell Cycle 9 2010 3022 3029